Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 8:09 pm Purchase |
2022-12-31 | 13G | Molecular Templates, Inc. MTEM |
BIOTECHNOLOGY VALUE FUND L P | 349,771 9.300% |
124,464 (+55.24%) |
Filing History |
| 2023-02-13 6:22 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BIOTECHNOLOGY VALUE FUND L P | 6,851,051 9.700% |
220,000 (+3.32%) |
Filing History |
| 2023-02-13 6:20 pm Purchase |
2022-12-31 | 13G | Lexicon Pharmaceuticals, Inc. LXRX |
BIOTECHNOLOGY VALUE FUND L P | 16,149,179 8.600% |
1,789,179 (+12.46%) |
Filing History |
| 2023-02-13 6:19 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 1,250,000 2.500% |
-3,641,945 (-74.45%) |
Filing History |
| 2023-02-13 6:17 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.700% |
253,900 (+7.16%) |
Filing History |
| 2023-02-13 6:14 pm Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% |
-118,366 (-6.14%) |
Filing History |
| 2023-02-13 6:13 pm Purchase |
2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
BIOTECHNOLOGY VALUE FUND L P | 2,938,851 8.400% |
1,147,500 (+64.06%) |
Filing History |
| 2023-02-13 6:11 pm Purchase |
2022-12-31 | 13G | Ikena Oncology, Inc. IKNA |
BIOTECHNOLOGY VALUE FUND L P | 2,503,071 6.900% |
704,700 (+39.19%) |
Filing History |
| 2023-02-13 6:08 pm Sale |
2022-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
BIOTECHNOLOGY VALUE FUND L P | 51,724 1.600% |
-178,206 (-77.50%) |
Filing History |
| 2023-02-13 6:05 pm Purchase |
2022-12-31 | 13G | Elevation Oncology, Inc. ELEV |
BIOTECHNOLOGY VALUE FUND L P | 2,312,200 9.900% |
700,502 (+43.46%) |
Filing History |
| 2023-02-13 6:02 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% |
1,321,017 (+36.73%) |
Filing History |
| 2023-02-13 6:00 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% |
437,500 (+13.09%) |
Filing History |
| 2023-02-13 5:57 pm Sale |
2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN |
BIOTECHNOLOGY VALUE FUND L P | 1,353,815 2.900% |
-235,680 (-14.83%) |
Filing History |
| 2023-02-13 5:55 pm Purchase |
2022-12-31 | 13G | Repare Therapeutics Inc. RPTX |
BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% |
150,000 (+1.84%) |
Filing History |
| 2023-02-13 5:53 pm Purchase |
2022-12-31 | 13G | AC Immune SA ACIU |
BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% |
366,000 (+5.18%) |
Filing History |
| 2023-02-13 5:53 pm Purchase |
2022-12-31 | 13G | Viracta Therapeutics, Inc. VIRX |
BIOTECHNOLOGY VALUE FUND L P | 3,833,785 9.980% |
102,041 (+2.73%) |
Filing History |
| 2023-02-13 5:51 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 2,258,400 1.900% |
-769,272 (-25.41%) |
Filing History |
| 2023-02-13 5:28 pm Purchase |
2023-02-03 | 13G | Structure Therapeutics Inc. GPCR |
BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% |
12,660,518 (New Position) |
Filing History |
| 2023-02-06 4:43 pm Purchase |
2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR |
BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% |
990,000 (New Position) |
Filing History |
| 2023-01-03 5:01 pm Purchase |
2022-12-22 | 13G | Zymeworks Inc. ZYME |
BIOTECHNOLOGY VALUE FUND L P | 5,870,000 9.300% |
5,870,000 (New Position) |
Filing History |